Searched for
PROFECTUS BIOSCIENCES INC
COVID-19 vaccine: Aurobindo Pharma expects phase-I, II trials by end of 2020He said the vaccine for COVID-19 is being developed by Profectus BioSciences Inc in US, which was acquired by AurobindoPharmas subsidiary A...- Aurobindo Pharma working on COVID-19 vaccine; shortlisted for BIRAC fundingIn November 2019, Aurobindo Pharma said its subsidiary Auro Vaccines LLC entered into a pact to acquire certain business assets from Profec...
- Single-dose Ebola vaccine developedResearchers have developed a quick-acting Ebola vaccine that is both safe and effective with a single dose against the strain of the virus ...
- Load More